NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00256776,MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation,https://clinicaltrials.gov/study/NCT00256776,,TERMINATED,"This is an international study in adult patients diagnosed with multiple myeloma who have already received at least one autologous stem cell transplantation and who have responded but later progressed, or relapsed, at least one year after transplantation.

Eligible patients will be randomly assigned to one of two treatments: either Velcade plus Thalidomide plus Dexamethasone or Thalidomide plus Dexamethasone.

Thalidomide and Velcade are two new agents that have recently become available for the treatment of multiple myeloma, especially in relapsed patients. This study therefore aims to test the hypothesis that the combination treatment with Velcade plus Thalidomide plus Dexamethasone will result in a longer time to progression (measure of time after the disease is treated until it starts to get worse) than Thalidomide plus Dexamethasone alone.",YES,Multiple Myeloma,DRUG: Velcade (Bortezomib)|DRUG: Thalidomide|DRUG: Dexamethasone,"Median Time to Progression (TTP), 3 year","Progression Free Survival, 3 year|Overall Survival (Interval Between Date of Randomization and Death From Any Cause, 1 year|Response Rate (Proportion of Subjects Who Achieve Complete, Partial, or Minimal Response), 1 year",,European Society for Blood and Marrow Transplantation,"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Celgene Corporation",ALL,"ADULT, OLDER_ADULT",PHASE3,269,NETWORK,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,EudraCT: 2005-001628-35|EBMT-CLWP: 42206611,2005-07,2013-12,2015-12,2005-11-22,2021-10-18,2021-10-18,"Karl-Franzens, Graz, Austria|Universitatsklinik, Innsbruck, Austria|Medizinische Universitaet Wien, Vienna, Austria|Wilhelminenspital, Vienna, Austria|St Joseph, Arlon, Belgium|RHMS, Baudour, Belgium|AZ St Jan, Brugge, Belgium|Bordet, Brussels, Belgium|Erasme CHU, Brussels, Belgium|Saint Luc, Brussels, Belgium|University Hospital, Brussels, Belgium|Saint Joseph, Gilly, Belgium|CH Jolimont, Haine-Saint-Paul, Belgium|Clinique Saint-Pierre, Ottignies, Belgium|UCL Mont-Godinne, Yvoir, Belgium|University Hospital, Brno, Czechia|Faculty Hospital, Olomouc, Czechia|CHU Amiens, Amiens, France|CHU Angers, Angers, France|Centre Hospitalier d'Antibes, Antibes, France|CHU Jean Minjoz, Besancon, France|Avicenne, Bobigny, France|Polyclinique Bordeaux Nord, Bordeaux, France|Morvan CHU, Brest, France|Hotel Dieu, Clermont-Ferrand, France|ARC CHU Dijon, Dijon, France|Hospitalier de Dunkerque, Dunkerque, France|Hopital Michallon, Grenoble, France|La Roche sur Yon, France|Centre Hospitalier du Havre, Le Havre, France|CHRU de Lille, Lille, France|Edouard Herriot, Lyon, France|Pierre Benite, Lyon, France|Metz, France|Centre Hospitalier de Mulhouse, Mulhouse, France|CHU Nancy, Nancy, France|Hotel Dieu, Nantes, France|Archet, Nice, France|Hopital Cochin, Paris, France|Hotel Dieu, Paris, France|Saint Antoine, Paris, France|Hopital Jean Bernard, Poitiers, France|Robert Debre, Reims, France|CHU Hopital Sud, Rennes, France|Henri Becquerel, Rouen, France|CHRU Tours, Tours, France|Klinikum Bremen, Bremen, Germany|University of Cologne, Cologne, Germany|University Hospital, Dresden, Germany|University Hospital, Hamburg, Germany|Medizinische Hochschule, Hannover, Germany|Uniklinik Leipzig, Leipzig, Germany|Universitatsklinikum Schleswig-Hostein, Lubeck, Germany|DKD Wiesbaden, Wiesbaden, Germany|Medizinische und Poliklinik II, Wurzburg, Germany|St Laszlo Hospital, Budapest, Hungary|University of Debrecen, Debrecen, Hungary|Rambam MC, Haifa, Israel|Sheba MC, Tel Hashomer, Israel|Ospedale SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|Ospedale Riuniti, Bergamo, Italy|AO Spedali Civili di Brescia, Brescia, Italy|Ospedale Maggiore, Catania, Italy|Ospedale Maggiore, Milan, Italy|Federico II, Naples, Italy|V. Cervello, Palermo, Italy|Azienda Ospedale BMM, Reggio di Calabria, Italy|A.O.S. Andrea, Rome, Italy|Kantonsspital Aarau, Aarau, Switzerland|Kantonsspital Baden, Baden, Switzerland|Kantonsspital, Basel, Switzerland|IOSI, Ospedale Civico, Bellinzona, Switzerland|Inselspital, Bern, Switzerland|Hopital Cantonal Universitaire, Geneva, Switzerland|CHUV, Lausanne, Switzerland|LA Onkologie/Medizin, Thun, Switzerland|Stadtdpital Triemli, Zurich, Switzerland|UniversitatsSpital, Zurich, Switzerland|Heartlands Hospital, Birmingham, United Kingdom|Addenbrookes, Cambridge, United Kingdom|Great Western Hospital, Swindon, United Kingdom",
